Eribulin: Oligopeptide Research Reference
Eribulin, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
Overview
Eribulin is a bioactive peptide with well-characterized properties and therapeutic applications. It is derived from Synthetic analog from Halichondria okadai lead.
Structure
| Property | Value |
|---|---|
| Name | Eribulin |
| Length | N/A | | Molecular Weight | 729.9 Da | | Source | Synthetic analog from Halichondria okadai lead | | Category | Marine Anti-Cancer Drug (Approved) |
Mechanism of Action
Inhibits microtubule polymerization, binds beta-tubulin at growing ends
Bioactivity
Anti-mitotic, anti-tumor
Therapeutic Potential
Approved for metastatic breast cancer, liposarcoma
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Eribulin: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept